JPY2,913.00
4.02% yesterday
Tokyo, Sep 27, 08:00 am CET
ISIN
JP3351100007
Symbol
6869
Sector

SYSMEX Stock price

JPY2,913.00
+125.50 4.50% 1M
+167.33 6.09% 6M
+293.67 11.21% YTD
+468.00 19.14% 1Y
-1,980.86 40.48% 3Y
+529.22 22.20% 5Y
+1,446.67 98.66% 10Y
Tokyo, Closing price Fri, Sep 27 2024
+112.50 4.02%
ISIN
JP3351100007
Symbol
6869
Sector

Key metrics

Market capitalization JPY1.75t
Enterprise Value JPY1.73t
P/E (TTM) P/E ratio 33.64
EV/FCF (TTM) EV/FCF 38.49
EV/Sales (TTM) EV/Sales 3.61
P/S ratio (TTM) P/S ratio 3.65
P/B ratio (TTM) P/B ratio 3.90
Dividend yield 0.36%
Last dividend (FY25) JPY10.00
Revenue growth (TTM) Revenue growth 13.88%
Revenue (TTM) Revenue JPY478.10b
EBIT (operating result TTM) EBIT JPY80.84b
Free Cash Flow (TTM) Free Cash Flow JPY44.90b
Cash position JPY76.76b
EPS (TTM) EPS JPY83.25
P/E forward 30.39
P/S forward 3.41
EV/Sales forward 3.38
Show more

Is SYSMEX a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,901 stocks worldwide.

SYSMEX Stock Analysis

Unlock Scores for Free

Analyst Opinions

15 Analysts have issued a SYSMEX forecast:

9x Buy
60%
6x Hold
40%

Analyst Opinions

15 Analysts have issued a SYSMEX forecast:

Buy
60%
Hold
40%

Financial data from SYSMEX

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '24
+/-
%
478,104 478,104
14% 14%
100%
- Direct Costs 225,976 225,976
15% 15%
47%
252,128 252,128
13% 13%
53%
- Selling and Administrative Expenses 102,359 102,359
21% 21%
21%
- Research and Development Expense 31,625 31,625
1% 1%
7%
118,144 118,144
10% 10%
25%
- Depreciation and Amortization 37,306 37,306
14% 14%
8%
EBIT (Operating Income) EBIT 80,838 80,838
8% 8%
17%
Net Profit 52,048 52,048
12% 12%
11%

In millions JPY.

Don't miss a Thing! We will send you all news about SYSMEX directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Sysmex Corp. engages in the healthcare business. It develops, manufactures, sells, exports, and imports diagnostic instruments, reagents. and software used in in-vitro diagnostics. It also provides clinical laboratory testing of blood, urine, and other specimens. Its products include instruments and reagents diagnostics for hemostasis, immunochemistry, clinical chemistry, urinalysis, and point-of-care (POC) testing. It operates through the following geographical segments: Japan, Americas, Europe, Middle East, and Africa (EMEA), China, and Asia Pacific. The company was founded by Taro Nakatani on February 20, 1968 and is headquartered in Kobe, Japan.

Head office Japan
CEO Hisashi Ietsugu
Employees 10,042
Founded 1968
Website www.sysmex.co.jp

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today